Commercialization, Licensing, Collaboratiion and Partnering

• SUPRAER Technology licensees can reserve agent and drug-specific applications for aerosol delivery and AUGASOME technologies.

• Our programs in emphysema and atopic asthma based on our proprietary and patented-filed drug delivery, forumulation and discovery technologies are available for partnering.

To determine how collaborating with KAER BioTherapeutics could benefit your organization, please contact Dr. Donovan Yeates at (760) 744-0075 or by e-mail at info@kaerbio.com